Mandelboim, M. et al. 2021. Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta). Archives of Clinical and Biomedical Research. 5, 5 (Oct. 2021), 794–802.